Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism γ-secretase modulators(Gamma-secretase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H23FN6 |
InChIKeyOHXQPMCUJTWQJA-QGZVFWFLSA-N |
CAS Registry2231075-94-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | Germany | 01 Jul 2018 |